Navigation Links
Shingles Vaccine Safe, Underutilized, Study Says
Date:4/23/2012

MONDAY, April 23 (HealthDay News) -- The shingles vaccine is generally safe and well tolerated by patients, according to a new study.

Shingles, which affects more than 1 million people each year in the United States, is a painful contagious rash caused by the dormant chickenpox virus, which can reactivate and replicate, damaging the nervous system.

Elderly people are especially at risk because immunity against the virus that causes shingles declines with age.

In this study, researchers looked at data from more than 193,000 adults 50 and older who received the shingles vaccine, also known as the herpes zoster vaccine, over two years. There was a small increased risk of local reactions (redness and pain) from one to seven days after vaccination. This finding matches the results of clinical trials.

The shingles vaccine did not increase the risk for cerebrovascular diseases; cardiovascular diseases; meningitis, encephalitis, and encephalopathy; Ramsay-Hunt syndrome; or Bell's palsy, the researchers said.

The study was published online April 23 in the Journal of Internal Medicine.

The study supports the vaccination recommendation from the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices "and reassures the general public that the vaccine is safe," study author Hung Fu Tseng, a research scientist with the Kaiser Permanente in Pasadena, Calif., said in a Kaiser news release.

Few people received the vaccine, which was licensed in 2006, the news release said. The CDC recommends it for healthy people aged 60 and older.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about shingles.

-- Robert Preidt

SOURCE: Kaiser Permanente, news release, April 23, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Children With Asthma at Higher Risk for Shingles: Study
2. Study finds shingles may be related to elevated risk of multiple sclerosis
3. UGA compound offers new hope for treatment of painful adult shingles
4. COPD May Make Shingles More Likely
5. Shingles Returns More Often Than Thought
6. Shingles Vaccine Looks Like a Safe Bet for Seniors: Study
7. Qutenza Now Available for Treatment of Post-Shingles Pain
8. Welsh shingles drug set for final hurdle
9. A physicians guide for anti-vaccine parents
10. Army researcher develops potential vaccine carrier
11. Brain Tumor Vaccine Shows Promise in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shingles Vaccine Safe, Underutilized, Study Says
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: